| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000005629 |
| Receipt No. | R000006653 |
| Scientific Title | Pregnancy Associated Cardiomyopathy and Hypertension-Essential Research |
| Date of disclosure of the study information | 2011/05/26 |
| Last modified on | 2020/12/28 (Ver. 12) |
| Basic information | ||
| Public title | Pregnancy Associated Cardiomyopathy and Hypertension-Essential Research | |
| Acronym | PREACHER | |
| Scientific Title | Pregnancy Associated Cardiomyopathy and Hypertension-Essential Research | |
| Scientific Title:Acronym | PREACHER | |
| Region |
|
|
| Condition | |||
| Condition | Peripartum Cardiomyopathy and Pregnancy Associated Cardiomyopathy | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Although peripartum cardiomyopathy and pregnancy associated cardiomyopathy are life-threatening cardiomyopathy, little was known about the characteristics of this disease in Japan. We performed a nationwide questionnaire survey of PPCM cases in 2007 and 2008 and incidence (1/20,000 deliveries), risk factors (age, complication of hypertension, multiple births, and tocolytic therapy), and several clinical problems became clear. In this prospective study, we investigate further about detail medical histories, risk factors (especialy hypertension), long term outcomes, treatment, and laboratory parameters. |
| Basic objectives2 | Others |
| Basic objectives -Others | Clinical epidemiology research |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | -One year follow-up
(at diagnosis, 1-2 weeks later, 3 months later, 6 monthes later, 1 year later) -medical history -in cases with hypertension details of clinical course of pregnancy -vitals -ECG -UCG -laboratory data |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | (1) Development of heart failure during pregnancy or within the first 5 postpartum months
(2) No determinable etiology for cardiac failure (3) No history of heart disease prior to pregnancy (4) Reduced left ventricular contraction based on a left ventricular ejection fraction (LVEF) <50% |
|||
| Key exclusion criteria | not applicable above | |||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Mie University Graduate School of Medicine | ||||||
| Division name | Department of Obstetrics and Gynecology | ||||||
| Zip code | 5140001 | ||||||
| Address | 2-174 Edobashi, Tsu, MIE | ||||||
| TEL | 059-232-1111 | ||||||
| t-ikeda@clin.medic.mie-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | National Cerebral and Cardiovascular Center | ||||||
| Division name | The clinical investigation group for peripartum cardiomyopathy | ||||||
| Zip code | 5658564 | ||||||
| Address | 6-1kishibeshinmachi, Suita, Osaka Japan | ||||||
| TEL | 06-6170-1070 | ||||||
| Homepage URL | |||||||
| ppcm@ncvc.go.jp | |||||||
| Sponsor | |
| Institute | National Cerebral and Cardiovascular Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | National Cerebral and Cardiovascular Center |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | National Cerebral and Cardiovascular Center |
| Address | 6-1 Kishibeshinmachi Suita, Osaka Japan |
| Tel | 06-6170-1070 |
| chiz@ncvc.go.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立循環器病研究センター(大阪府)、症例登録施設 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Prospective study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006653 |